The rising prevalence in GLP-1 agonists for diabetes has generated a debate about application forms : patches versus tablets . Traditionally , GLP-1 therapies were only available in pill form, but the https://poppykipu970441.59bloggers.com/41307867/glp-1-transdermal-delivery-systems-vs-pills-is-right-for-the-patient